H.C. Wainwright Downgrades Cerevel Therapeutics (CERE) to Neutral
Tweet Send to a Friend
H.C. Wainwright analyst Douglas Tsao downgraded Cerevel Therapeutics (NASDAQ: CERE) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
